αs1-CN f (143–149) (acetate)
αs1-CN f (143–149) acetate is an orally active casein-derived peptide sequence. αs1-CN f (143–149) acetate exhibits angiotensin-converting enzyme (ACE) inhibitory activity (IC50=6.58 μM) and antihypertensive activity[1].
Product Specifications
UNSPSC
12352209
Target
Angiotensin-converting Enzyme (ACE)
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cardiovascular Disease
Purity
99.32
Smiles
OC(C=C1)=CC=C1C[C@H](NC([C@@H](NC([C@@H](NC([C@@H](N)C)=O)CC2=CC=C(C=C2)O)=O)CC3=CC=CC=C3)=O)C(N4[C@@H](CCC4)C(N[C@@H](CCC(O)=O)C(N[C@H](C(O)=O)CC(C)C)=O)=O)=O.CC(O)=O.[x]
Molecular Formula
C46H59N7O12.xC2H4O2
Molecular Weight
902.00 (free base)
References & Citations
[1]M del Mar Contreras, et al. "Novel casein-derived peptides with antihypertensive activity." International dairy journal 19.10 (2009) : 566-573.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
040182-ML490 100 µL
PLOD3, NT (PLOD3, Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3, Lysyl hydroxylase 3) (MaxLight 490) discontinued
Sign In for Pricing
View Details